Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Mid-range Performer
1434.6000 -5.20 (-0.36%)
NSE Dec 29, 2025 15:31 PM
Volume: 146.2K
 

logo
Ipca Laboratories Ltd.
13 Nov 2025
1434.60
-0.36%
buy
by Motilal Oswal
Target: 1600 | Upside : 11.5%
Motilal Oswal
Ipca Laboratories (IPCA) delivered slightly better-than-expected revenue in 2QFY26, while EBITDA/PAT beat our estimates by 18%/22%.
 
Number of FII/FPI investors decreased from 270 to 254 in Sep 2025 qtr
More from Ipca Laboratories Ltd.
Recommended
IPO activity is high on listings, but low on subscriptions
| 29 Dec 2025, 05:02PM
Market closes lower, dragged down by foreign investor outflows and higher crude prices
Trendlyne Marketwatch | 29 Dec 2025, 04:01PM
IPCA Labs’ domestic formulations business to drive growth
| 05 Jul 2021